// App-Quantinova.ai

: Evaluation of delivered dose and treatment time of several mesh nebulizers under in vitro simulated use

Researchers

Presenter

  • Lois Slator

Principal Investigators

  • Filippo Quadrelli

  • Dirk von Hollen

  • Lucy Hardaker

Medical Centers

  • Respironics Respiratory Drug Delivery (uk Ltd, a business of Philips Electronics UK Limited, Chichester, United Kingdom

  • Respironics Inc., a Philips Healthcare company, Murraysville, United States of America

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Salbutamol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved